Daily Newsletter

29 August 2023

Daily Newsletter

29 August 2023

NHS launches programme to improve type 2 diabetes care

The initiative will provide personalised care to around 140,000 affected people aged between 18 and 39 years.

August 29 2023

The NHS in England has launched an initiative, the first of its kind globally, aimed at enhancing care for individuals under 40 years with early-onset type 2 diabetes.

Called 'T2Day: Type 2 Diabetes in the Young', the programme will provide personalised care to nearly 140,000 affected people aged between 18 and 39 years.

This covers customised health check-ups, support in managing diabetes-related aspects including blood sugar levels and weight, and the possibility of new treatments.

In addition, the programme offers specific assistance for pregnant women with diabetes, ensuring access to contraception and folic acid supplements.

The initiative is supported by £14.5m in funding and aims to mitigate health complications and reduce health disparities.

Eligible participants may also access the NHS Type 2 Diabetes Path to Remission Program, which involves a year-long approach to help improve blood sugar levels and potentially place type 2 diabetes into remission.

This will run alongside the successful NHS Type 2 Diabetes Path to Remission Program, which has demonstrated substantial weight loss benefits for participants.

National clinical director for diabetes and obesity Jonathan Valabhji said: “Type 2 diabetes in people under 40 is a growing problem globally – England is no exception, meaning there is an ever-increasing challenge for the NHS.

“We know this age group is least likely to complete vital annual health checks but we want to ensure people are able to manage their diabetes well and reduce the risk of serious complications, which is exactly why we have embarked on an ambitious and world-first initiative called T2Day: Type 2 Diabetes in the Young.

“The programme will provide targeted intervention for each person under the age of 40 living with type 2 diabetes, including additional reviews focused on completing proven diabetes care processes, managing blood sugar levels, weight management, preparation for pregnancy, and supporting any unmet psychological or social needs.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close